Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer

    Cancer research, Vol. 82, Núm. 24, pp. 4670-4679

2014

  1. Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy

    Journal of the National Cancer Institute, Vol. 106, Núm. 11